Results 121 to 130 of about 24,396 (218)

The changing epidemiology of human type 2 diabetes–associated atherosclerosis: Pathophysiological mechanisms and emerging treatment possibilities

Journal of Internal Medicine, Volume 300, Issue 2, Page 131-152, August 2026.
Abstract Type 2 diabetes (T2D) is a major global health concern strongly associated with atherosclerosis and subsequent macrovascular complications. These complications are the leading cause of death among T2D patients. Despite a decline in cardiovascular events over the last decade, individuals with T2D still have an approximately doubled risk ...
Dania Al‐Sharify, Jiangming Sun, Andreas Edsfeldt   +2 more
wiley   +1 more source

Irinotecan Modulates Immune Checkpoints in Neuroblastoma. [PDF]

Immunotargets Ther
Lapidus T, Zorde-Khvalevsky E, Jolani A, Goldstein G, Peled A.   +4 more
europepmc   +1 more source

Emerging Immune‐Based Therapeutic Strategies in Hepatocellular Carcinoma

Liver International, Volume 46, Issue 8, August 2026.
ABSTRACT Hepatocellular carcinoma (HCC) remains a leading cause of cancer‐related mortality worldwide despite recent advances in systemic therapy. The introduction of immune checkpoint inhibitors has substantially expanded treatment options for advanced disease; however, durable responses are observed only in a subset of patients.
Janine Kah, Werner Dammermann, Stefan Lueth   +2 more
wiley   +1 more source

CD20; CD47 [PDF]

Science-Business eXchange, 2010
openaire   +1 more source

The EphA3 Antibody Enhances CD47 Antibody-Mediated Phagocytosis by Repolarizing M2-Like Tumor-Associated Macrophages in a Preclinical Model of Recurrent Head and Neck Cancer. [PDF]

Onco Targets Ther
Kim SH, Kim JW, Kim MS, Cha HJ, Kim SW, Han MW.   +5 more
europepmc   +1 more source

Myeloid Malignancies Beyond the Cell: Targeting the Tumour Microenvironment with Next-Generation Immunotherapies. [PDF]

Cancers (Basel)
Amirian N, Squires A, Azanabor L, Walker CL, Simmonds MJ, Rinaldi C.   +5 more
europepmc   +1 more source

Commentary: the TSP-1-CD47-integrin α4β1 axis-deciphering pathogenic mechanisms and therapeutic horizons in rheumatoid arthritis. [PDF]

Inflamm Res
Guo J, Mai FY, Li XY, Liu Y, Liang JR, Li XL, Li CG.   +6 more
europepmc   +1 more source

Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference. [PDF]

Blood Neoplasia
Lustig M, Kowol M, Hartmann AM, van der Peet IC, Jansen MJH, Iben K, Winterberg D, Krohn S, Baumann N, Rösner T, Bendig S, Hahn C, Wurm AA, Gehlert CL, Denker M, Suwanchaikasem P, Macarrón Palacios A, Schwartz S, Brüggemann M, Burger R, Schmitt K, Klausz K, Valerius O, Stölzel F, Bastian L, Baldus CD, Peipp M, Leusen JHW, Schewe DM, Valerius T.   +29 more
europepmc   +1 more source

B7-H3 (CD276) and CD47 Expression Are Associated with Immune Evasion and Survival Outcomes in Pediatric Medulloblastoma. [PDF]

Diagnostics (Basel)
Abat E, Abat EG, Emrullahoğlu Y, Yüceer RO, Mazıcı S, Durmuş NA, Şahin A, Ulutabanca H, Oral Ş, Özcan A, Canöz Ö, Küçük A.   +11 more
europepmc   +1 more source

CD47-mediated purification of human ventricular cardiomyocytes derived from pluripotent stem cells. [PDF]

Anim Cells Syst (Seoul)
Park SJ, Choi HK, Park KH, Park NK, Moon SH.   +4 more
europepmc   +1 more source